Literature DB >> 21331670

A multicenter study of vesicovaginal fistula following incidental cystotomy during benign hysterectomies.

Thinh H Duong1, David P Taylor, G Rodney Meeks.   

Abstract

INTRODUCTION AND HYPOTHESIS: To evaluate factors for vesicovaginal fistula (VVF) formation following incidental cystotomies during benign hysterectomies.
METHODS: Hysterectomies performed at two university centers between January 1, 2000 and December 31, 2008 were reviewed. Demographic and operative data were abstracted. Patients who developed VVF were compared to those with no VVF.
RESULTS: During the study period, 5,698 hysterectomies performed for benign indications were identified. One hundred two (1.8%) cystotomies occurred with 6 (5.9%) developing a VVF. Patients with VVF were more likely to have uteri weighing > 250 g (83% vs. 36%, P = 0.03), had longer surgeries (317 ± 82 vs. 208 ± 10 min, P = 0.02) and more ureteral injuries (33% vs. 1%, P = 0.009). American Association for the Surgery of Trauma (AAST) grade V bladder injuries (OR, 93.00; 95% CI, 10.30-838.92) were associated with VVF formation.
CONCLUSIONS: Patients with AAST grade V bladder injuries are at increased risk for developing vesicovaginal fistulas following incidental cystotomies during benign hysterectomies.

Entities:  

Mesh:

Year:  2011        PMID: 21331670     DOI: 10.1007/s00192-011-1375-6

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  12 in total

1.  Outreach programmes for obstetric fistulae.

Authors:  J Kelly
Journal:  J Obstet Gynaecol       Date:  2004-02       Impact factor: 1.246

2.  Organ injury scaling. III: Chest wall, abdominal vascular, ureter, bladder, and urethra.

Authors:  E E Moore; T H Cogbill; G J Jurkovich; J W McAninch; H R Champion; T A Gennarelli; M A Malangoni; S R Shackford; P G Trafton
Journal:  J Trauma       Date:  1992-09

3.  Risk factors for the development of vesicovaginal fistula after incidental cystotomy at the time of a benign hysterectomy.

Authors:  Thinh H Duong; Tara L Gellasch; Rony A Adam
Journal:  Am J Obstet Gynecol       Date:  2009-08-15       Impact factor: 8.661

Review 4.  Current status of genitourinary fistula.

Authors:  R A Lee; R E Symmonds; T J Williams
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

5.  Inpatient hysterectomy surveillance in the United States, 2000-2004.

Authors:  Maura K Whiteman; Susan D Hillis; Denise J Jamieson; Brian Morrow; Michelle N Podgornik; Kate M Brett; Polly A Marchbanks
Journal:  Am J Obstet Gynecol       Date:  2007-11-05       Impact factor: 8.661

6.  Surgery for the obstetric vesicovaginal fistula: a review of 100 operations in 82 patients.

Authors:  T E Elkins
Journal:  Am J Obstet Gynecol       Date:  1994-04       Impact factor: 8.661

7.  Hysterectomy for benign indications and risk of pelvic organ fistula disease.

Authors:  Catharina Forsgren; Cecilia Lundholm; Anna L V Johansson; Sven Cnattingius; Daniel Altman
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

8.  Urinary tract injury during hysterectomy based on universal cystoscopy.

Authors:  Okechukwu A Ibeanu; Ralph R Chesson; Karolynn T Echols; Mily Nieves; Fatuma Busangu; Thomas E Nolan
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

9.  Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience.

Authors:  W E Goodwin; P T Scardino
Journal:  J Urol       Date:  1980-03       Impact factor: 7.450

10.  Observations on prevention and management of vesicovaginal fistula after total hysterectomy.

Authors:  M L Tancer
Journal:  Surg Gynecol Obstet       Date:  1992-12
View more
  4 in total

Review 1.  State of the Art for Treatment of Vesicovaginal Fistula.

Authors:  Rachel A Moses; E Ann Gormley
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

2.  Lower urinary tract injuries during hysterectomy in women with a history of two or more cesarean deliveries: a secondary analysis.

Authors:  Thinh H Duong; Tamula M Patterson
Journal:  Int Urogynecol J       Date:  2014-02-13       Impact factor: 2.894

3.  Platelet-Rich Plasma as Adjuvant Therapy for Recurrent Vesicovaginal Fistula: A Prospective Case Series.

Authors:  Dominika Streit-Ciećkiewicz; Konrad Futyma; Paweł Miotła; Magdalena Emilia Grzybowska; Tomasz Rechberger
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

4.  Continent vesicovaginal fistula.

Authors:  Luís Gustavo Morato de Toledo; Victor Espinheira Santos; Paulo Eduardo Gourlat Maron; Bruno César Vedovato; Moacyr Fucs; Marjo Deninson Cardenuto Perez
Journal:  Einstein (Sao Paulo)       Date:  2013 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.